Evommune, INC. (EVMN) — S-1 Filings
All S-1 filings from Evommune, INC.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
Evommune Files S-1 for IPO, Advances Chronic Inflammation Pipeline
— Oct 9, 2025 Risk: high
Evommune, Inc. (EVMN) is a clinical-stage biotechnology company focused on chronic inflammatory diseases, filing an S-1 for its initial public offering. The com
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX